vs

Side-by-side financial comparison of CASTLE BIOSCIENCES INC (CSTL) and Xperi Inc. (XPER). Click either name above to swap in a different company.

Xperi Inc. is the larger business by last-quarter revenue ($116.5M vs $83.7M, roughly 1.4× CASTLE BIOSCIENCES INC). Xperi Inc. runs the higher net margin — -14.7% vs -17.4%, a 2.7% gap on every dollar of revenue. On growth, Xperi Inc. posted the faster year-over-year revenue change (-4.8% vs -4.9%). Over the past eight quarters, Xperi Inc.'s revenue compounded faster (-1.0% CAGR vs -1.9%).

Castle Biosciences Inc. is a commercial-stage diagnostic firm that develops and markets proprietary, clinically actionable tests for dermatological conditions such as melanoma and other skin cancers, plus rare diseases. It operates mainly in the U.S. healthcare market, focusing on segments with high unmet need for more accurate diagnostics to guide treatment choices.

Xperi Inc. is an American multinational technology company headquartered in San Jose, California, that develops software for consumer electronics and connected cars, as well as media platforms for video service over broadband. The company is organized into four business units: Pay TV, Consumer Electronics, Connected Car, and Media Platform. Xperi's brands include DTS, HD Radio, and TiVo.

CSTL vs XPER — Head-to-Head

Bigger by revenue
XPER
XPER
1.4× larger
XPER
$116.5M
$83.7M
CSTL
Growing faster (revenue YoY)
XPER
XPER
+0.1% gap
XPER
-4.8%
-4.9%
CSTL
Higher net margin
XPER
XPER
2.7% more per $
XPER
-14.7%
-17.4%
CSTL
Faster 2-yr revenue CAGR
XPER
XPER
Annualised
XPER
-1.0%
-1.9%
CSTL

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CSTL
CSTL
XPER
XPER
Revenue
$83.7M
$116.5M
Net Profit
$-14.5M
$-17.1M
Gross Margin
Operating Margin
-12.7%
Net Margin
-17.4%
-14.7%
Revenue YoY
-4.9%
-4.8%
Net Profit YoY
43.8%
-137.0%
EPS (diluted)
$-0.49
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CSTL
CSTL
XPER
XPER
Q1 26
$83.7M
Q4 25
$87.0M
$116.5M
Q3 25
$83.0M
$111.6M
Q2 25
$86.2M
$105.9M
Q1 25
$88.0M
$114.0M
Q4 24
$86.3M
$122.4M
Q3 24
$85.8M
$132.9M
Q2 24
$87.0M
$119.6M
Net Profit
CSTL
CSTL
XPER
XPER
Q1 26
$-14.5M
Q4 25
$-17.1M
Q3 25
$-501.0K
$-6.1M
Q2 25
$4.5M
$-14.8M
Q1 25
$-25.8M
$-18.4M
Q4 24
$46.2M
Q3 24
$2.3M
$-16.8M
Q2 24
$8.9M
$-30.3M
Gross Margin
CSTL
CSTL
XPER
XPER
Q1 26
Q4 25
79.0%
Q3 25
77.5%
Q2 25
79.5%
Q1 25
81.4%
Q4 24
81.3%
Q3 24
81.8%
Q2 24
83.3%
Operating Margin
CSTL
CSTL
XPER
XPER
Q1 26
Q4 25
-4.4%
-12.7%
Q3 25
-8.2%
-1.2%
Q2 25
-4.9%
-10.5%
Q1 25
-31.7%
-14.4%
Q4 24
4.7%
-11.7%
Q3 24
5.9%
-14.0%
Q2 24
5.8%
-18.3%
Net Margin
CSTL
CSTL
XPER
XPER
Q1 26
-17.4%
Q4 25
-14.7%
Q3 25
-0.6%
-5.5%
Q2 25
5.2%
-14.0%
Q1 25
-29.4%
-16.1%
Q4 24
37.8%
Q3 24
2.6%
-12.6%
Q2 24
10.3%
-25.3%
EPS (diluted)
CSTL
CSTL
XPER
XPER
Q1 26
$-0.49
Q4 25
$-0.06
$-0.37
Q3 25
$-0.02
$-0.13
Q2 25
$0.15
$-0.32
Q1 25
$-0.90
$-0.41
Q4 24
$0.32
$1.02
Q3 24
$0.08
$-0.37
Q2 24
$0.31
$-0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CSTL
CSTL
XPER
XPER
Cash + ST InvestmentsLiquidity on hand
$63.8M
$96.8M
Total DebtLower is stronger
$10.1M
$27.7M
Stockholders' EquityBook value
$461.4M
$414.1M
Total Assets
$547.8M
$615.8M
Debt / EquityLower = less leverage
0.02×
0.07×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CSTL
CSTL
XPER
XPER
Q1 26
$63.8M
Q4 25
$299.5M
$96.8M
Q3 25
$287.5M
$96.8M
Q2 25
$275.9M
$95.1M
Q1 25
$275.2M
$88.0M
Q4 24
$293.1M
$130.6M
Q3 24
$95.0M
$72.7M
Q2 24
$85.6M
$92.5M
Total Debt
CSTL
CSTL
XPER
XPER
Q1 26
$10.1M
Q4 25
$10.1M
$27.7M
Q3 25
$10.0M
$27.7M
Q2 25
$10.0M
$27.7M
Q1 25
$10.0M
$27.7M
Q4 24
$10.0M
$27.7M
Q3 24
$10.0M
$27.7M
Q2 24
$10.0M
$27.7M
Stockholders' Equity
CSTL
CSTL
XPER
XPER
Q1 26
$461.4M
Q4 25
$470.9M
$414.1M
Q3 25
$467.0M
$421.0M
Q2 25
$455.4M
$419.8M
Q1 25
$440.3M
$418.9M
Q4 24
$455.8M
$429.1M
Q3 24
$441.1M
$377.4M
Q2 24
$423.9M
$388.7M
Total Assets
CSTL
CSTL
XPER
XPER
Q1 26
$547.8M
Q4 25
$578.6M
$615.8M
Q3 25
$562.8M
$628.8M
Q2 25
$544.7M
$629.2M
Q1 25
$501.7M
$633.5M
Q4 24
$531.2M
$667.8M
Q3 24
$514.6M
$616.2M
Q2 24
$487.3M
$619.2M
Debt / Equity
CSTL
CSTL
XPER
XPER
Q1 26
0.02×
Q4 25
0.02×
0.07×
Q3 25
0.02×
0.07×
Q2 25
0.02×
0.07×
Q1 25
0.02×
0.07×
Q4 24
0.02×
0.06×
Q3 24
0.02×
0.07×
Q2 24
0.02×
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CSTL
CSTL
XPER
XPER
Operating Cash FlowLast quarter
$-22.1M
$4.1M
Free Cash FlowOCF − Capex
$1.2M
FCF MarginFCF / Revenue
1.0%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-5.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CSTL
CSTL
XPER
XPER
Q1 26
$-22.1M
Q4 25
$26.9M
$4.1M
Q3 25
$22.6M
$7.5M
Q2 25
$20.8M
$10.1M
Q1 25
$-6.0M
$-22.3M
Q4 24
$24.4M
$1.2M
Q3 24
$23.3M
$-4.6M
Q2 24
$24.0M
$-2.1M
Free Cash Flow
CSTL
CSTL
XPER
XPER
Q1 26
Q4 25
$19.7M
$1.2M
Q3 25
$7.8M
$6.7M
Q2 25
$11.6M
$9.5M
Q1 25
$-10.8M
$-23.3M
Q4 24
$16.8M
$-510.0K
Q3 24
$17.0M
$-5.6M
Q2 24
$18.8M
$-2.6M
FCF Margin
CSTL
CSTL
XPER
XPER
Q1 26
Q4 25
22.7%
1.0%
Q3 25
9.4%
6.0%
Q2 25
13.4%
9.0%
Q1 25
-12.2%
-20.5%
Q4 24
19.5%
-0.4%
Q3 24
19.8%
-4.2%
Q2 24
21.6%
-2.2%
Capex Intensity
CSTL
CSTL
XPER
XPER
Q1 26
Q4 25
8.3%
2.5%
Q3 25
17.9%
0.7%
Q2 25
10.7%
0.5%
Q1 25
5.4%
0.9%
Q4 24
8.8%
1.4%
Q3 24
7.4%
0.8%
Q2 24
6.0%
0.4%
Cash Conversion
CSTL
CSTL
XPER
XPER
Q1 26
Q4 25
Q3 25
Q2 25
4.60×
Q1 25
Q4 24
0.03×
Q3 24
10.29×
Q2 24
2.69×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CSTL
CSTL

Segment breakdown not available.

XPER
XPER

Pay TV$56.2M48%
Connected Car$31.3M27%
Consumer Electronics$17.2M15%
Media Platform$11.8M10%

Related Comparisons